CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The EFFecT Doctoral Training Network focuses on advancing RNA-based therapeutics, particularly antisense oligonucleotides. It aims to educate the next generation of experts by addressing challenges in drug delivery and fostering collaboration across academia and industry.
The EFFecT Doctoral Training (DN) Network responds to the evolving landscape of RNA-based therapeutics and in particular antisense oligonucleotides (ASO).
Over the last 25 years, only 21 antisense nucleic acid-based molecules have been approved by the FDA or/and EMA.
However, the field is now at the tipping point of maturity to achieve regular translation from bench to bed side, provided that certain obstacles are successfully addressed.
Our consortium involves experts from academia, industry, a…
STICHTING RADBOUD UNIVERSITAIR MEDISCH CENTRUM
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Spain, Madrid
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Spain, Barakaldo Bizkaia
Type: Research institute
Activity type: Research Organisations
SME: No
UNIVERSITE DE VERSAILLES SAINT-QUENTIN-EN-YVELINES.
France, VERSAILLES
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
